|Day Low/High||53.26 / 53.79|
|52 Wk Low/High||39.35 / 56.50|
The New Jersey-based animal health company reported better-than-expected fourth quarter earnings Thursday, but shares fell 5%.
The company lowered guidance for FY 2017, which is likely to blame for the company's fall.
Ackman launched a winning activist campaign at Chipotle last year.
The consumer finally has some fun money to spare. That is the good news.
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2016 and updated its guidance for the full year 2017.
Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company a license for Stronghold ® Plus (selamectin/sarolaner), a topical combination of parasiticides that treats ticks,...
Billionaire Bill Ackman has completely cashed out of his stake in animal health company Zoetis, instead making a big bet on fast food company Chipotle.
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2017 dividend payable to holders of the company's common stock of $0.
Investors should keep an eye on interest rates and oil, but remember next week is still a week of big earnings reports, says Jim Cramer.
Cramer shares his views on the pajama traders, and talks turkey about pet stocks.
Cramer can't understand why shares of Johnson Controls spinoff Adient aren't trading higher.
Going into earnings what the market needs now is more negativity, Cramer says.
The Mars-VCA deal is yet another sign that pet health is a robust business.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #56 spot from Kraft Heinz Co , according to ETF Channel. Below is a chart of Zoetis Inc versus Kraft Heinz Co plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; KHC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.
Zoetis Inc. (NYSE:ZTS) will participate in the 35th Annual J.
Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has authorized a $1.
In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.
A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.
The troubled drugmaker's new CFO hinted that 2017 top- and bottom-line figures would be lower than 2016 levels.
Jim Cramer ponders the preciousness of credibility.
Jim Cramer says the market can have many winners.
Zoetis shares were climbing off an earnings beat and raised 2016 guidance.